Faso Food and Drug Administration (Faso FDA): strengthening regulatory systems for public health protection in Burkina Faso
Year: 2026
Type: article
Abstract: In May 2026, the Government of Burkina Faso established Faso Food and Drug Administration (Faso FDA) by Decree No. 2026-0602/PF/PRIM/MEF/MS. This unified regulatory authority mandated to oversee food products, health commodities, industrial chemicals, cosmetics, pesticides, and other products with potential public health risks. Endowed with legal personality and administrative and financial autonomy, the Agency should operate independently and mitigate risks related to corruption and conflicts of interest. Its scope aligns with that of other African national regulatory authorities such as the Ghana Food and Drugs Authority and the Rwanda Food and Drugs Authority. The legal establishment of Faso FDA is only the first step and to fully deliver on its mandate, this young regulatory authority must address six strategic priorities: securing sustainable domestic financing; strengthening governance systems and transparency; ensuring adequate infrastructure and technical capacity; developing a competent and sufficient workforce; achieving World Health Organization (WHO) Global Benchmarking Tool (GBT) Maturity Level 3; and bolstering regional and international collaboration. Addressing these priorities will position Faso FDA as a robust regulatory authority capable of safeguarding public health and promoting sustainable local production of safe, high-quality food and medical products.
Language: English
Topic: Healthcare Regulation
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,353
OpenAlex ID: W7221819307